Discover 1,760 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,760
Active & Responsive
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Detroit MI, Houston TX, Santa Fe NM, Duarte CA,
Sponsor: Xerient Pharma
Sex: All
Age: 18+
Code: NCT07157033
Phase 1, Phase 2, Recruiting
Active & Responsive
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
for
Advanced Solid Cancers
Location: Detroit MI, New York NY, Orlando FL, Denver CO
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07186842
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Detroit MI, Grand Rapids MI, Hamilton, Toronto,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07114601
Phase 1, Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Detroit MI, Chicago IL, Milwaukee WI, Buffalo NY,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase 3, Recruiting
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: Detroit MI, Cleveland OH, Amherst NY, Louisville KY,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
for
Hemophilia A
Location: Detroit MI, Chicago IL, Indianapolis IN, Cincinnati OH,
Sponsor: Wayne State University
Sex: All
Age: 6 - 19
Code: NCT05022459
Recruiting
Active & Responsive
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis (AD)
Location: Auburn Hills MI, Warren MI, Clinton Township MI,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07298395
Phase 2, Recruiting
Active & Responsive
Family Intervention for Black Teens With Type 1 Diabetes
for
Type 1 Diabetes, Family Relations
Location: Detroit MI, Washington D.C. DC, Memphis TN
Sponsor: Wayne State University
Sex: All
Age: 10 - 14
Code: NCT06275412
Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Troy MI, Erie PA, Oakville, Toronto, Newport News VA,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase 3, Recruiting
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Troy MI, Sarnia, Hamilton, Indianapolis IN, Fairfax VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07412756
Phase 3, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Troy MI, Skokie IL, Beaver PA, Duncansville PA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Troy MI, Sarnia, Guelph, Hamilton, Stoney Creek,
Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC
for
HIPEC
Location: Detroit MI
Sponsor: Henry Ford Health System
Sex: All
Age: 18+
Code: NCT05426928
Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: Grosse Pointe Woods MI, Chicago IL, Lombard IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase 3, Recruiting
Active & Responsive
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
for
Acute Ischemic Stroke
Location: Toledo OH, Mount Clemens MI, Lansing MI, Flint MI,
Sponsor: Mercy Health Ohio
Sex: All
Age: 18 - 70+
Code: NCT05611242
Phase 3, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed